PubMed COVID-19 Clinical Care

BACKGROUND: Hemostatic disturbances with coronavirus disease 2019 (COVID-19) can predispose to tricuspid and right heart thrombi in very rare instances.

CONCLUSIONS: When combined dexamethasone and LTIs provided a mortality benefit in COVID-19 patients presenting with an O(2) saturations <50%. The LTI cohort had lower markers of inflammation and cytokine storm.

CONCLUSIONS: Life style behaviours were affected during lockdown period. Higher amounts of food intake and snaking were increased. Physical activity was at a moderate level, increased sedentary behaviour was reported by most participants during

LPS-responsive beige-like anchor protein (LRBA) deficiency is a primary immunodeficiency caused by a mutation in the LRBA gene. Affected individuals present with a variety of clinical symptoms including hypogammaglobulinemia, recurrent infections

No abstract

The ongoing COVID-19 pandemic is caused by SARS-CoV-2. Although several effective vaccines that target the Spike protein on the viral surface have been deployed, additional therapeutic agents are urgently needed. Here we developed a system to measure

No abstract

Inflammasomes are cytosolic innate immune sensors of pathogen infection and cellular damage that induce caspase-1-mediated inflammation upon activation. Although inflammation is protective, uncontrolled excessive inflammation can cause inflammatory

COVID-19 vaccines provide high levels of protection against severe disease and hospitalization due to SARS-CoV-2 infection. Vaccination may be less effective in preventing shedding of infectious virus from otherwise immune patients. In this study, we

No abstract